Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-01

Clinical Trial Update: PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

View source ↗

Summary

This completed PRIDE trial evaluated the efficacy, adherence and tolerability of a single-pill bisoprolol/perindopril combination in patients with coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol/perindopril fixed-dose combination (bisoprolol and perindopril)

Snippet

Sponsor: Servier Russia | Conditions: Coronary Artery Disease, Myocardial Infarction | Status: COMPLETED | Results posted: 2024-11-01